AIO Circle request access

Hotel Palace Berlin · 10–11 February 2027

The batchrecord is signed.
The model is not.

Who governs.  ·  Who decides.  ·  Who is accountable.

The gap · Manufacturing

AI is makingthe call.
Nobody has governed it.

AI is generating release-critical decisions in bioprocessing. Batch release. Process deviation. Yield prediction. The models are running inside GMP environments. The accountability layer above those decisions — the leader who governs the output and carries the consequence — does not yet exist on most org charts.

The VP Manufacturing signs the batch record. The AI model informed the decision. Nobody has formally governed the handoff. That gap is structural. It will not close itself.

Models now generate release-critical calls no one has formally governed. The line between AI ambition and AI outcome is the officer who carries both.

The imperative · three premises

01
The accountability is missing.

AI-driven automation is compressing timelines. Digital twins are simulating process performance before capital is committed. The technology is deployed. The governance is not. Every board in life sciences will appoint the role. Few yet have the candidate — or the framework the candidate needs to operate inside.

02
The regulatory frontier is moving.

FDA and EMA are building their posture toward AI-enabled CMC submissions in real time. The organisations that have already built the governance architecture — the validation framework, the data provenance layer, the internal accountability structure — will define what the standard becomes. Those that wait will inherit it.

03
The data layer sets the ceiling.

Every AI prediction in manufacturing is downstream of the data it trained on. If the architecture is fragmented — departmental silos, disconnected PAT streams, unstructured batch records — every governance model built on top inherits that fragmentation. The structure the model governs is built before the model runs.

The Conversation · AIO Circle Berlin 2027

Up to 30 leaders.Curated. Invite only.

AIO Circle convenes the leaders preparing for the AI governance role — across manufacturing and bioprocess. Two 30-minute talks. One 30-minute panel. The people who carry the accountability question in the same room, for 90 minutes. No conference floor. No vendor showcase.

Co-located with BILS 2027 and CGTI 2027 at Hotel Palace Berlin. The manufacturing governance conversation sits inside the largest gathering of biomanufacturing leadership in Europe outside BPI.

30
Curated leaders · by invitation only · not by application
90
Minutes · two talks · one panel · no schedule overhead
70%+
VP-level and above · principals only
Hotel Palace Berlin · Budapester Strasse 45 · 10787
10–11 February 2027 · co-located with BILS and CGTI
Next conversation scheduled
Hotel Palace Berlin · February 2027
View the Conversations →

Previous voices · Manufacturing & Bioprocess

Who has held it.

2026 faculty. Not confirmed for 2027. Announced in cadence with the programme.

PP
Philip Probert
Director, Biologics & RNA · Centre of Excellence
CPI
BILS/AIO 2026
AD
Andreia Duarte
EMEA Commercial Director
GenScript
BILS/AIO 2026
JZ
Jesús Zurdo
Director
ARA Biosciences
BILS/AIO 2026
UG
Uwe Gottschalk
Operating Partner · Forum Co-Chair
Keensight Capital · Former CSO, Lonza
DDIF 2026 · BILS/AIO 2026
HP
Dr Harsukh Parmar
Former SVP, Global Head R&ED
EMD Serono / Merck KGaA
DDIF 2026 · BILS/AIO 2026

2027 faculty announced in cadence with the programme.  View confirmed voices →

AIO Circle · Berlin 2027

The manufacturinggovernance conversation.

Request a place → View the Conversations →

By invitation · by nomination · by direct introduction.